Please assess the completion status of the following clinical trial:

Trial Title: Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elective major abdominal surgery for neoplasm~* Planned admission to postsurgical ICU due to the patient's meeting one or more of the following:~  * ASA Physical Status Class 4~ * Surgery of modified Johns-Hopkins class ≥IV~ * ASA 3 with modified Johns-Hopkins class 3 surgery~ * Expected duration of surgery ≥8 h~Exclusion Criteria:~* History of coagulation abnormalities, either congenital or acquired~* Ongoing treatment with anticoagulants/antiplatelet agents other than LMWH or hormones~* Massive edema of the legs~* Severe peripheral arteriopathy or neuropathy~* Malformations or recent surgery/trauma to the lower extremities

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SCD + LMWH (Type: EXPERIMENTAL): This group will receive sequential compression device therapy to the lower limbs from their ICU admission until the morning after surgery.
- LMWH only (Type: ACTIVE_COMPARATOR): Patients in this group will receive only standard LMWH therapy during their ICU stay.

Based on this trial design, predict the completion outcome and termination type (if applicable).